Assuming advance is required, the following results were found.

  • 'This Is Going to Be a Huge Advance': What We Heard This Week

    "I really think this is going to be a huge advance in Alzheimer's disease." -- Howard Fillit, MD, of the Alzheimer's Drug Discovery Foundation in New York City, on a blood-based biomarker that detected Alzheimer's disease. "I was told, 'This has never...

    https://www.mschristian.org/index.php/articles/2-uncategorised/11077-this-is-going-to-be-a-huge-advance-what-we-heard-this-week
  • Senior Planner - Chico Enterprise-Record

    months immediately following the Golden Grill). Feather River Senior Center: open 10 a.m.-1 p.m. Senior mealsstart at noon. Advance 24-hour reservations required, 898-4224. Senior Meals: Noon at Lakeside Pavilion. $2.50 for 60+; $6 for under 60....

    https://www.mschristian.org/index.php/component/easyblog/senior-planner-chico-enterprise-record-1?Itemid=341
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    (MS) research, which provides insights into disease progression, including data from Ocrevus®(ocrelizumab) trials that advance understanding of neurofilament light chain (NfL) levels as a potential biomarker for predicting disability outcomes....

    https://www.mschristian.org/index.php/component/easyblog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims?Itemid=341
  • UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

    allo will focus on those with early-stage Alzheimer's who have the genetic risk factor for the disease. We are thrilled to advance allo as the first regenerative therapeutic for Alzheimer's and to bring innovations in the brain science of the future to...

    https://www.mschristian.org/index.php/component/easyblog/ua-receives-37-5-million-nih-grant-to-research-potential-regenerative-therapy-for-alzheimer-s?Itemid=341
  • A molecular switch for repairing damage in central nervous system disorders discovered

    in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of...

    https://www.mschristian.org/index.php/component/easyblog/a-molecular-switch-for-repairing-damage-in-central-nervous-system-disorders-discovered?Itemid=341
  • Molecular switch for repairing central nervous system disorders

    in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of...

    https://www.mschristian.org/index.php/component/easyblog/molecular-switch-for-repairing-central-nervous-system-disorders?Itemid=341
  • 3-8 Local business briefs - Norman Transcript

    of intensive collaboration and networking” and is “carefully designed to provide students with the exact tools they need to advance.” According to Ivy Exec’s website, “the University of Oklahoma’s Executive MBA in Energy not only provides the core...

    https://www.mschristian.org/index.php/component/easyblog/3-8-local-business-briefs-norman-transcript?Itemid=341
  • Guest Op-ed: Who Makes Christmas? - Lynn Journal

    herself out preparing for events like Thanksgiving and Christmas. She started preparing the Thanksgiving meal two weeks in advance and for sure we had a feast. For some time now she has been in charge of locating the right Christmas gift for children...

    https://www.mschristian.org/index.php/component/easyblog/guest-op-ed-who-makes-christmas-lynn-journal?Itemid=341
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest advancements in diagnosis and treatment of multiple sclerosis (MS) proves challenging. Many neurologists—even those who spend most...

    https://www.mschristian.org/index.php/component/easyblog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction?Itemid=341
  • CorTechs Labs Enters Phase 2 of $1.15 Million NIH Grant to Automate the Diagnosis and Prediction of Alzheimer's Disease - Business Wire

    with similar manifestations, such as Lewy body dementia or cerebral amyloid angiopathy. “PETQuant yields a remarkable advance in the interpretation of PET scans, providing physicians with objective quantification of tracer binding in native brain...

    https://www.mschristian.org/index.php/component/easyblog/cortechs-labs-enters-phase-2-of-1-15-million-nih-grant-to-automate-the-diagnosis-and-prediction-of-alzheimer-s-disease-business-wire?Itemid=341
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    collaboration between world-class research teams during a time of explosive growth in our understanding of the research advances possible in space is a great privilege. We are delighted to be funding such innovative science at the frontier of new drug...

    https://www.mschristian.org/index.php/component/easyblog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire?Itemid=341
  • A molecular key for delaying the progression of Multiple Sclerosis is found

    system and damaging it. These therapies are effective in the early phases of the disease, but they do not prevent its advance and the progressive functional deterioration. During the progressive phase of the disease it is the microglial cells in the...

    https://www.mschristian.org/index.php/component/easyblog/a-molecular-key-for-delaying-the-progression-of-multiple-sclerosis-is-found?Itemid=341
  • A molecular switch for repairing damage in central nervous system disorders discovered

    in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of...

    https://www.mschristian.org/index.php/articles/2-uncategorised/9793-a-molecular-switch-for-repairing-damage-in-central-nervous-system-disorders-discovered
  • Vapor association files suit against US FDA over application deadline

    “FDA’s constantly shifting regulatory process is wholly unreasonable, unfair and unlawful. The Agency has failed to provide advance notice or an opportunity for public comment as required by the Administrative Procedure Act. Grossly accelerating the...

    https://www.mschristian.org/index.php/component/easyblog/vapor-association-files-suit-against-us-fda-over-application-deadline?Itemid=341
  • Horizon Discovery expands cell-based CRISPR screening services

    or diseased micro-environments, enabling them to better understand disease etiology and therapeutic mechanisms, and thereby advance drug discovery and development programs. Related Stories Horizon has already applied its gene editing and cell culture...

    https://www.mschristian.org/index.php/component/easyblog/horizon-discovery-expands-cell-based-crispr-screening-services?Itemid=341
  • NMSU graduate lands job analyzing data for HIV/AIDS research - Las Cruces Sun-News

    University all the way to the University of Washington, where she recently launched her career as a statistician working to advance the prevention, detection and treatment of HIV infection and AIDS. Valenzuela earned two degrees from NMSU, including a...

    https://www.mschristian.org/index.php/component/easyblog/nmsu-graduate-lands-job-analyzing-data-for-hiv-aids-research-las-cruces-sun-news?Itemid=341
  • Experts: Call for Vape Bans Made Covid-19 Worse

    Photo: Vchalup | Dreamstime.com Anti-vaping activist groups continue to use the coronavirus crisis to advance their goal of restricting — or even completely banning — the use of vapor products. They argue that vapers are at higher risk of harm from...

    https://www.mschristian.org/index.php/component/easyblog/experts-call-for-vape-bans-made-covid-19-worse?Itemid=341
  • UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

    allo will focus on those with early-stage Alzheimer's who have the genetic risk factor for the disease. We are thrilled to advance allo as the first regenerative therapeutic for Alzheimer's and to bring innovations in the brain science of the future to...

    https://www.mschristian.org/index.php/articles/2-uncategorised/8466-ua-receives-37-5-million-nih-grant-to-research-potential-regenerative-therapy-for-alzheimer-s
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    collaboration between world-class research teams during a time of explosive growth in our understanding of the research advances possible in space is a great privilege. We are delighted to be funding such innovative science at the frontier of new drug...

    https://www.mschristian.org/index.php/articles/2-uncategorised/9425-first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Molecular switch for repairing central nervous system disorders

    in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of...

    https://www.mschristian.org/index.php/articles/2-uncategorised/9808-molecular-switch-for-repairing-central-nervous-system-disorders

Results 1 - 20 of 50